DE60216906D1 - Anti-pilyrosporum ovale igy und dessen verwendung - Google Patents

Anti-pilyrosporum ovale igy und dessen verwendung

Info

Publication number
DE60216906D1
DE60216906D1 DE60216906T DE60216906T DE60216906D1 DE 60216906 D1 DE60216906 D1 DE 60216906D1 DE 60216906 T DE60216906 T DE 60216906T DE 60216906 T DE60216906 T DE 60216906T DE 60216906 D1 DE60216906 D1 DE 60216906D1
Authority
DE
Germany
Prior art keywords
ovale
pityrosporum ovale
igy
lgy
pilyrosporum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60216906T
Other languages
English (en)
Other versions
DE60216906T8 (de
DE60216906T2 (de
Inventor
Jong-Hwa Lee
Jung Sakong
Dong-Il Jang
Chang-Seon Yu
Ki-Ho Jang
Jin-Hee Jun
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COTDE Inc
Lee & Joe Biotech Co
Original Assignee
COTDE Inc
Lee & Joe Biotech Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COTDE Inc, Lee & Joe Biotech Co filed Critical COTDE Inc
Publication of DE60216906D1 publication Critical patent/DE60216906D1/de
Application granted granted Critical
Publication of DE60216906T2 publication Critical patent/DE60216906T2/de
Publication of DE60216906T8 publication Critical patent/DE60216906T8/de
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
  • Hydroponics (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
DE60216906T 2001-04-14 2002-04-15 Anti-pilyrosporum ovale igy und dessen verwendung Expired - Fee Related DE60216906T8 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2001020004 2001-04-14
KR10-2001-0020004A KR100446856B1 (ko) 2001-04-14 2001-04-14 항비듬균 면역항체와 그 용도
PCT/KR2002/000685 WO2002083737A1 (en) 2001-04-14 2002-04-15 Anti pilyrosporum ovale lgy and its uses

Publications (3)

Publication Number Publication Date
DE60216906D1 true DE60216906D1 (de) 2007-02-01
DE60216906T2 DE60216906T2 (de) 2007-07-26
DE60216906T8 DE60216906T8 (de) 2008-01-17

Family

ID=19708259

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60216906T Expired - Fee Related DE60216906T8 (de) 2001-04-14 2002-04-15 Anti-pilyrosporum ovale igy und dessen verwendung

Country Status (8)

Country Link
EP (1) EP1379556B1 (de)
JP (1) JP4002187B2 (de)
KR (1) KR100446856B1 (de)
CN (1) CN1524091A (de)
AT (1) ATE348842T1 (de)
DE (1) DE60216906T8 (de)
ES (1) ES2274966T3 (de)
WO (1) WO2002083737A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2746394A4 (de) 2011-08-19 2015-07-15 Ostrich Pharma Kk Antikörper und antikörper enthaltende zusammensetzung
CA3062868A1 (en) * 2016-08-01 2018-02-08 Scaled Microbiomics, Llc Systems and methods for altering microbiome to reduce disease risk and manifestations of disease
CN111295094A (zh) 2017-10-09 2020-06-16 泰尔茂比司特生物技术有限公司 冻干容器及使用冻干容器的方法
MX2020012225A (es) 2018-05-17 2021-01-29 Procter & Gamble Sistemas y metodos para el analisis de la cobertura del cabello.
US11172873B2 (en) 2018-05-17 2021-11-16 The Procter & Gamble Company Systems and methods for hair analysis
US11384357B2 (en) 2018-06-29 2022-07-12 The Procter And Gamble Company Aptamers for personal care applications
JP7226766B2 (ja) * 2018-10-17 2023-02-21 オーストリッチファーマ株式会社 毛髪の改善のための抗体
JP2022525398A (ja) 2019-03-14 2022-05-13 テルモ ビーシーティー バイオテクノロジーズ，エルエルシー 凍結乾燥容器用充填治具、システム及び使用方法
CA3134968A1 (en) 2019-04-16 2020-10-22 Juan Esteban Velasquez Aptamers for odor control applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1271682B (it) * 1994-07-19 1997-06-04 Indena Spa Determinazione e isolamento di taxolo e 10-desacetil-bacatina iii e analoghi attraverso anticorpi
WO2001019871A2 (en) * 1999-09-16 2001-03-22 Unilever Plc Delivery system for antidandruff agent

Also Published As

Publication number Publication date
KR20020079238A (ko) 2002-10-19
ATE348842T1 (de) 2007-01-15
JP4002187B2 (ja) 2007-10-31
DE60216906T8 (de) 2008-01-17
KR100446856B1 (ko) 2004-09-04
ES2274966T3 (es) 2007-06-01
EP1379556A4 (de) 2005-02-09
WO2002083737A1 (en) 2002-10-24
CN1524091A (zh) 2004-08-25
JP2005502594A (ja) 2005-01-27
DE60216906T2 (de) 2007-07-26
EP1379556A1 (de) 2004-01-14
EP1379556B1 (de) 2006-12-20

Similar Documents

Publication Publication Date Title
EA200401198A1 (ru) АНТИТЕЛА ПРОТИВ αvβ6
DE60329489D1 (de) Fusionsproteine humanisierter g250-spezifischer antikörper sowie verwendungen davon
NZ597023A (en) Monoclonal antibodies that bind to hGM-CSF and medical compositions comprising same
EA200800812A1 (ru) Композиции антитела против cd3
EA200600390A1 (ru) Химерные антигены для нарушения толерантности хозяина к чужеродным антигенам
TW200714290A (en) Anti-M-CSF antibody compositions having reduced levels of endotoxin
DE69433663D1 (de) Antikörper gegen menschliches prostatspezifisches drüsenkallikrein
PT994903E (pt) Metodos e composicoes para glicoproteinas galactosiladas
NO20063224L (no) Anti-MPL-antistoff
JO3000B1 (ar) مركبات أجسام مضادة .
DE602006006200D1 (de) Antikörper gegen 25-hydroxyvitamin d
ATE465181T1 (de) Humanisierte anti-cmet-antagonisten
WO2007129895A3 (en) Deimmunized antagonistic anti-human cd40 monoclonal antibody from the ch5d12 antibody
HK1071586A1 (en) Transplant acceptance inducing cells of monocytic origin and their preparation and use
ATE382683T1 (de) Monoklonales antikörper gegen das hcv kernantigen
SG146644A1 (en) Kid3 and kid3 antibodies that bind thereto
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
MX2023004054A (es) Anticuerpos anti-dectina 1 y metodos de uso de los mismos.
DE60216906T8 (de) Anti-pilyrosporum ovale igy und dessen verwendung
WO1998022510A3 (en) Methods for the production of chicken monoclonal antibodies
NZ595863A (en) Antibodies to egfl7 and methods for their use
JOP20220204A1 (ar) الأجسام المضادة لـ cd19 البشرية
ATE477274T1 (de) Gegen clostridium difficile gerichtete antikörper
ATE546524T1 (de) Verfahren zur herstellung aktiver scfv-antikörper und bibliotheken dafür
ATE370163T1 (de) Antikörper zur isolierung und/oder identifizierung mesenchymaler stammzellen und verfahren zur isolierung und/oder identifizierung mesenchymaler stammzellen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee